High Throughput Screening (HTS) Market 2025–2029: Tracking 8.7% CAGR Toward $35.29 Billion in Revenue

Uncover key drivers, emerging technologies, and competitive movements shaping the high throughput screening (hts) market from 2025–2034 with trusted insights from The Business Research Company

How Will The High Throughput Screening (HTS) Market Size Evolve Between Now And 2029?

The high throughput screening (hts) market size has seen substantial growth over recent years. It is projected to increase from $22.98 billion in 2024 to $25.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.9%. This historical growth can be attributed to several factors, including the rising adoption of high-throughput screening, increased R&D spending, enhanced availability of funds for research, growing healthcare expenditure, and a competitive market environment.

The high throughput screening (hts) market is anticipated to show robust expansion in the forthcoming years. It is projected to reach a value of $35.29 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This projected increase is attributable to the expanding market and its growth momentum, strategic initiatives undertaken by major industry players, the escalating need for disease monitoring and drug discovery, the increasing incidence of chronic diseases, and an elevated emphasis on deploying ultra high throughput screening (UHTS) techniques. Significant trends during the forecast period encompass technological advancements within high-throughput screening and a sustained focus on integrating ultra high throughput screening (UHTS) techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

Which Key Drivers Are Powering Growth In The High Throughput Screening (HTS) Market?

The increasing prevalence of chronic diseases is projected to drive the expansion of the high-throughput screening (HTS) market in the future. A chronic disease is defined as a long-term health condition or ailment that persists over an extended period, typically for three months or longer. HTS enables the rapid screening of numerous chemical compounds to identify potential drug candidates targeting specific pathways or mechanisms involved in chronic diseases, which is essential for their effective long-term management. For instance, in January 2023, according to the National Library of Medicine, a US-based government agency, the number of individuals in the US aged 50 and older with at least 1 chronic condition is expected to rise to 142.66 million by 2050. Therefore, the growing prevalence of chronic diseases will propel the growth of the high-throughput screening (HTS) market.

How Is The Global High Throughput Screening (HTS) Market Structured By Key Segments?

The high throughput screening (hts) market covered in this report is segmented –

1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

Subsegments:

1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

What Future-Focused Trends Are Anticipated In The High Throughput Screening (HTS) Market?

Leading companies active in the high-throughput screening market are developing innovative products, such as multimode plate readers, to better serve their clientele with advanced functionalities. A multimode plate reader (MPR) is a sophisticated laboratory instrument used in high-throughput screening, analyzing biological and chemical samples in microplates by integrating multiple detection modes for diverse assays within a single platform. For instance, in February 2023, PerkinElmer Inc., a US-based MedTech company, launched the EnVision Nexus system. The EnVision Nexus system distinguishes itself as the fastest and most sensitive multimode plate reader available, explicitly designed for demanding high-throughput screening (HTS) applications to expedite drug discovery efforts. With its unique technology, including dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, coupled with the latest reagent kits, the platform offers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with walkaway convenience options such as a plate stacker for 20 or 50 plates or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with unprecedented efficiency.

Which Companies Hold A Competitive Edge In The High Throughput Screening (HTS) Market?

Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Which Region Is Expected To Lead The High Throughput Screening (HTS) Market In The Next Few Years?

North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2025, By The Business Research Company

Prenatal Testing And Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Drug Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Employment Screening Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795